Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Oct. 02, 2022
Oct. 03, 2021
Oct. 02, 2022
Oct. 03, 2021
Income Statement [Abstract]        
Revenue $ 8 $ 0 $ 5,109 $ 0
Cost of revenue 6,629 104 12,883 1,847
Gross margin (6,621) (104) (7,774) (1,847)
Operating expenses:        
Research and development 13,948 10,301 42,506 25,413
Selling, general and administrative 13,110 8,791 36,545 17,500
Total operating expenses 27,058 19,092 79,051 42,913
Loss from operations (33,679) (19,196) (86,825) (44,760)
Other income (expense):        
Change in fair value of convertible preferred stock warrants and common stock warrants (50,160) 8,460 44,040 3,679
Interest expense, net 0 (52) 0 (187)
Other income (expense), net 1,826 (50) 2,344 (38)
Total other income (expense), net (48,334) 8,358 46,384 3,454
Net loss $ (82,013) $ (10,838) $ (40,441) $ (41,306)
Net loss per share, basic (in dollars per share) $ (0.53) $ (0.08) $ (0.27) $ (0.38)
Weighted average number of common shares outstanding, basic (in shares) 153,332,007 133,492,216 152,497,010 109,317,614
Net loss per share, diluted (in dollars per share) $ (0.53) $ (0.14) $ (0.55) $ (0.45)
Weighted average number of common shares outstanding, diluted (in shares) 153,332,007 135,052,128 153,773,271 109,854,540